Congresswoman Diana DeGette

Representing the First District of Colorado
Twitter icon
Facebook icon
YouTube icon
Instagram icon
  • New Leadership in the New Congress

    As the new Chair of Energy and Commerce's Oversight and Investigations subcommittee, it is now my responsibility to ensure that some of our most prominent federal agencies are working in the best interest of Americans. I will work tirelessly to ensure that they are working for us -- and that means taking real, meaningful steps to combat climate change and make health care more affordable for all Americans. --Diana DeGette
  • Gun Violence Prevention

    Americans are demanding that Congress pass sensible gun safety legislation. I'm continuing my ongoing work to make these reforms a reality, which will help keep all of our communities safer.
  • Fulfilling DACA's Promise

    President Trump's decision to rescind DACA is a crushing blow to more than 17,000 DREAMers in Colorado, but our fight isn't over. I will continue working to pass legislation, such as the Dream Act, that helps these young men and women remain in this country and achieve their American dream.

Home Page Tabs

Join me on Facebook

Latest News

Apr 18, 2019 Press Release

WASHINGTON, D.C. – U.S. Rep. Diana DeGette (D-CO) released the following statement on the release of Special Counsel Robert Mueller’s report:

Apr 18, 2019 Press Release

WASHINGTON, D.C. – A trio of senior U.S. lawmakers, including Rep.

Apr 18, 2019 Press Release

DENVER, CO – U.S. Rep. Diana DeGette (D-CO) said today it’s “unacceptable” that the future state of Colorado’s economy lies in the hands of one person.

Apr 11, 2019 Press Release

WASHINGTON, D.C. – Reps. Diana DeGette (D-CO) and Bill Johnson (R-OH) introduced the Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians (HELLPP) Act, yesterday. The bipartisan legislation will improve patient access to podiatrists in Medicaid and improve care for patients with diabetes who need therapeutic shoes via Medicare. 

Apr 10, 2019 Press Release

WASHINGTON, D.C. – “The system is broken,” U.S. Rep. Diana DeGette (D-CO), chair of the House oversight panel that’s currently investigating the rising cost of insulin, told a panel of drug makers and pharmacy executives who were summoned to appear before Congress today to explain why the cost of the life-saving drug has continued to rise in recent years.